6
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Thrombolytic therapy in acute MI

Weighing the risks and benefits

Pages 79-93 | Published online: 17 May 2016
 

Preview

Enthusiasm for thrombolytic agents has led to an explosion of research and clinical trials. These have yielded diverse conclusions, usually because of differences in patient enrollment, end points analyzed, and treatment protocols. Some of the resulting misconceptions about this rapidly changing field are clarified in this concise review.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.